Centessa Pharmaceuticals Files 8-K on Shareholder Vote Matters
Ticker: CNTA · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1847903
| Field | Detail |
|---|---|
| Company | Centessa Pharmaceuticals PLC (CNTA) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, 8-k
Related Tickers: CNTA
TL;DR
Centessa Pharma (CNTA) filed an 8-K for shareholder vote matters. Standard governance update.
AI Summary
Centessa Pharmaceuticals plc filed an 8-K on June 20, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's corporate structure and its status as a public entity incorporated in England and Wales.
Why It Matters
This filing indicates that Centessa Pharmaceuticals is engaging in corporate governance activities requiring shareholder approval, which is a standard but important part of operating as a public company.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding shareholder votes and does not indicate any immediate financial or operational risks.
Key Players & Entities
- Centessa Pharmaceuticals plc (company) — Registrant
- June 20, 2025 (date) — Date of Report
- England and Wales (jurisdiction) — State of incorporation
- 001-40445 (company_id) — Commission File Number
FAQ
What specific matters were submitted to a vote of Centessa Pharmaceuticals plc's security holders?
The filing states that it is a "Submission of Matters to a Vote of Security Holders" but does not detail the specific matters in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported is June 20, 2025, which is also the date of the report.
Where is Centessa Pharmaceuticals plc's principal executive office located?
The principal executive offices are located at 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, WA14 2DT, United Kingdom.
What is Centessa Pharmaceuticals plc's Commission File Number?
Centessa Pharmaceuticals plc's Commission File Number is 001-40445.
Under which section of the Securities Exchange Act of 1934 is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Centessa Pharmaceuticals plc (CNTA).